Executive Management

Oleg Movchan is the Chief Executive Officer of Enfusion. As an Enfusion founding investor, Mr. Movchan played a key role in Enfusion’s early product and technology evolution and was deeply involved in scaling the business over the years. Mr. Movchan has been an Enfusion client at several investment firms and joined the Enfusion Board of Directors in 2021 after serving on the Board of Managers since 2009.

Mr. Movchan’s experience in the asset management, investment banking, and operating industries spans more than 27 years across both public and private capital markets. He previously served as the Chief Risk Officer and Head of Risk Management for multiple asset management firms overseeing hedge funds, fund-of-funds and other investment vehicles, including UBS Global Asset Management, Ritchie Capital Management, Alexandra Investment Management, and Attalus Capital. He is a Founder and Managing Partner of Gimel Tech Ventures, a private equity and venture capital investment platform specializing in applications of technology in financial services, cyber security, real estate, and healthcare.

Additionally, Mr. Movchan is a founding investor in Revolution Global, a vertically integrated consumer packaged goods operating platform. During his tenure (from inception in 2014 through 2021), Mr. Movchan held various senior leadership roles, including Chief Investment Officer, Chief Strategy Officer, Deputy CEO, and Board Member.

A graduate of the General Management Program from Aresty Institute of Executive Education at the University of Pennsylvania’s Wharton School, Mr. Movchan earned a MS in Financial Mathematics and an MBA in Analytic Finance from the University of Chicago. He received a MS in Applied Mathematics and Physics from Kharkov State University, Ukraine. Mr. Movchan also holds a CFA designation.

Bradley Herring joined Enfusion as Chief Financial Officer in 2022 with more than 30 years of experience in finance leadership.

Prior to Enfusion, Herring served as Chief Financial Officer for multiple fintech companies, including Shift4 Payments, LLC, Elavon, Inc., and the digital banking group of Fiserv. Herring holds a Bachelor of Arts degree in Management and Economics and a Masters of Business Administration from Georgia Institute of Technology Scheller College of Business.

Dan Groman is Chief Technology Officer at Enfusion. He leads Enfusion’s Software Development, Product Management, IT, and Security teams.

Previously, he served as a Systems Engineer at CME Group. He began his career in asset management and hedge funds at Northern Trust Hedge Fund Services and King Street Capital Management. He holds a bachelor’s degree in Economics from the University of Maryland and a master’s degree in Computer Science from DePaul University.

Bronwen Bastone is Chief People Officer at Enfusion. She is responsible for rapidly scaling Enfusion’s approach to human resources. She has 20 years of experience in HR leadership roles across multiple industries, including institutional finance.

Previously, she led HR at Exos, a B2B institutional finance platform. She has also held senior HR roles at Knight Capital, Merrill Lynch, Cushman Wakefield, Brookfield Asset Management, and Southwest Power Pool. She holds an MBA from the University of Technology, Sydney (Australia).

Dan Jacobs serves as Global Head of Sales at Enfusion where he oversees all revenue generation efforts. He has been with Enfusion for 11+ years, having served in a variety of roles including as an Implementation and Business Development Specialist and as the Global Head of Business Development, responsible for strategic initiatives that drive sales and new business, before moving onto his current role.

Jacobs has 15+ years of experience in the investment management industry, including five years spent at WR Managed Holdings, where he served as Vice President of Risk Management.

He holds a bachelor's degree from Georgetown University.

John Falcone is the Head of Managed Services, where he leads the teams responsible for providing fully-integrated, outsourced, middle- and back-office services and operations support to hedge funds and investment managers.

"Our client relationships are grounded in confidence and trust which we continuously cultivate through subject matter expertise and hard work. Our clients benefit from the fact that we hire experienced people from the hedge fund and asset management community who truly understand the client’s needs and wants. In fact, we often anticipate what our clients might need before they even ask."

Prior to joining Enfusion in 2021, Falcone served as the Director of Operations at New York-based hedge fund Marble Ridge Capital. In this role, he was responsible for managing all aspects of the fund’s middle and back office, including day-to-day operations, and utilized the Enfusion platform. He served as the direct point of contact for all prime brokerage and administrative relationships, a member of the Risk and Valuation committee, and the leader of the Operational Due Diligence team.

Falcone has more than 30 years of industry experience and has held multiple senior executive roles leading operations for hedge funds, asset managers, and securities servicers, including Sandelman Partners, Eagle River Asset Management, Charter Bridge Capital, and Bank of America Securities.

Falcone received his bachelor’s degree in History from John Jay College of Criminal Justice.

Joseph Vayalattu is Head of Client Services at Enfusion where he is responsible for the new client journey, from discovery and implementation through to live trading and beyond. His team ensures a stellar onboarding experience as well as ongoing lifetime success.

"Enfusion offers a best-in-class product, the result of great innovation and forward thinking. Combine that with the support of a spectacular team, always striving to put the client first, and you have an unmatched client experience."

Vayalattu first joined Enfusion in 2013 where he was tasked with setting up the firm’s client support infrastructure as the Global Head of Product Consulting. He then served as the Global Head of Onboarding, where he assisted in building out the formation of Enfusion’s onboarding team.

Vayalattu has spent 12+ years in the financial services industry, with specializations in hedge funds and technology management. Prior to joining Enfusion, he worked as a derivatives analyst at J.P. Morgan.

Vayalattu holds a bachelor’s degree and a Master’s of Science, both from New York University’s Polytechnic School of Engineering.